-
Je něco špatně v tomto záznamu ?
The association between radiographic progression, functional impairment, markers of dyslipidaemia and inflammation in patients with hand osteoarthritis: a five-year longitudinal study
J. Baloun, X. Švec, LA. Cerezo, O. Růžičková, O. Šléglová, J. Gatterová, M. Tomčík, J. Vencovský, K. Pavelka, L. Šenolt
Jazyk angličtina Země Itálie
Typ dokumentu časopisecké články
- MeSH
- biologické markery * krev MeSH
- časové faktory MeSH
- dyslipidemie * krev diagnostické zobrazování MeSH
- funkční status MeSH
- klouby ruky * diagnostické zobrazování MeSH
- krevní sedimentace MeSH
- lidé středního věku MeSH
- lidé MeSH
- longitudinální studie MeSH
- mediátory zánětu krev MeSH
- osteoartróza * diagnostické zobrazování krev MeSH
- posuzování pracovní neschopnosti MeSH
- prediktivní hodnota testů MeSH
- progrese nemoci * MeSH
- radiografie MeSH
- senioři MeSH
- stupeň závažnosti nemoci MeSH
- zánět krev diagnostické zobrazování MeSH
- Check Tag
- lidé středního věku MeSH
- lidé MeSH
- mužské pohlaví MeSH
- senioři MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
OBJECTIVES: This study aimed to investigate the associations between radiographic damage, serum biomarkers, and clinical assessments in Czech patients with hand osteoarthritis (HOA) over a five-year follow-up period. METHODS: The study cohort comprised 129 patients diagnosed with HOA, including 72 patients with an erosive subtype and 57 patients with a non-erosive subtype. Radiographs were evaluated using the Kallman scoring system by two independent readers. Blood samples were analysed for markers of dyslipidaemia, bone metabolism, and inflammation. Clinical assessments focused on symptom severity and functional impairment. We employed generalised additive modelling (GAM) to analyse the associations between the Kallman score, serum biomarkers and clinical outcomes. RESULTS: The Kallman score was consistently higher in the erosive subtype compared to the non-erosive subtype across all time points and demonstrated a positive correlation with age in both groups. We demonstrated significant positive associations between radiographic progression and erythrocyte sedimentation rate across both HOA subtypes. Additionally, positive associations with the number of swollen joints and health assessment questionnaire scores were observed in all HOA patients, particularly in those with non-erosive subtypes. In contrast, markers of dyslipidaemia (e.g. LDL‐c or atherogenic index) were negatively associated with radiographic progression. No biomarker reliably differentiated between the erosive and non-erosive subtypes. CONCLUSIONS: Our longitudinal study revealed a significant association between systemic/local inflammation, dyslipidaemia, functional impairment and structural progression in HOA. However, these findings warrant further validation through additional studies to confirm these associations.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc25009689
- 003
- CZ-PrNML
- 005
- 20250429134537.0
- 007
- ta
- 008
- 250415s2025 it f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.55563/clinexprheumatol/9b9fnm $2 doi
- 035 __
- $a (PubMed)39808271
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a it
- 100 1_
- $a Baloun, Jiří $u Institute of Rheumatology, and Department of Rheumatology, 1st Faculty of Medicine, Charles University, Prague, Czech Republic
- 245 14
- $a The association between radiographic progression, functional impairment, markers of dyslipidaemia and inflammation in patients with hand osteoarthritis: a five-year longitudinal study / $c J. Baloun, X. Švec, LA. Cerezo, O. Růžičková, O. Šléglová, J. Gatterová, M. Tomčík, J. Vencovský, K. Pavelka, L. Šenolt
- 520 9_
- $a OBJECTIVES: This study aimed to investigate the associations between radiographic damage, serum biomarkers, and clinical assessments in Czech patients with hand osteoarthritis (HOA) over a five-year follow-up period. METHODS: The study cohort comprised 129 patients diagnosed with HOA, including 72 patients with an erosive subtype and 57 patients with a non-erosive subtype. Radiographs were evaluated using the Kallman scoring system by two independent readers. Blood samples were analysed for markers of dyslipidaemia, bone metabolism, and inflammation. Clinical assessments focused on symptom severity and functional impairment. We employed generalised additive modelling (GAM) to analyse the associations between the Kallman score, serum biomarkers and clinical outcomes. RESULTS: The Kallman score was consistently higher in the erosive subtype compared to the non-erosive subtype across all time points and demonstrated a positive correlation with age in both groups. We demonstrated significant positive associations between radiographic progression and erythrocyte sedimentation rate across both HOA subtypes. Additionally, positive associations with the number of swollen joints and health assessment questionnaire scores were observed in all HOA patients, particularly in those with non-erosive subtypes. In contrast, markers of dyslipidaemia (e.g. LDL‐c or atherogenic index) were negatively associated with radiographic progression. No biomarker reliably differentiated between the erosive and non-erosive subtypes. CONCLUSIONS: Our longitudinal study revealed a significant association between systemic/local inflammation, dyslipidaemia, functional impairment and structural progression in HOA. However, these findings warrant further validation through additional studies to confirm these associations.
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 12
- $a progrese nemoci $7 D018450
- 650 12
- $a osteoartróza $x diagnostické zobrazování $x krev $7 D010003
- 650 12
- $a biologické markery $x krev $7 D015415
- 650 _2
- $a lidé středního věku $7 D008875
- 650 _2
- $a longitudinální studie $7 D008137
- 650 12
- $a dyslipidemie $x krev $x diagnostické zobrazování $7 D050171
- 650 _2
- $a senioři $7 D000368
- 650 12
- $a klouby ruky $x diagnostické zobrazování $7 D050823
- 650 _2
- $a zánět $x krev $x diagnostické zobrazování $7 D007249
- 650 _2
- $a radiografie $7 D011859
- 650 _2
- $a stupeň závažnosti nemoci $7 D012720
- 650 _2
- $a mediátory zánětu $x krev $7 D018836
- 650 _2
- $a časové faktory $7 D013997
- 650 _2
- $a funkční status $7 D000085542
- 650 _2
- $a posuzování pracovní neschopnosti $7 D004185
- 650 _2
- $a krevní sedimentace $7 D001799
- 650 _2
- $a prediktivní hodnota testů $7 D011237
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Švec, Xiao $u Institute of Rheumatology, and Department of Rheumatology, 1st Faculty of Medicine, Charles University, Prague, Czech Republic
- 700 1_
- $a Cerezo, Lucie Andrés $u Institute of Rheumatology, and Department of Rheumatology, 1st Faculty of Medicine, Charles University, Prague, Czech Republic
- 700 1_
- $a Růžičková, Olga $u Institute of Rheumatology, and Department of Rheumatology, 1st Faculty of Medicine, Charles University, Prague, Czech Republic
- 700 1_
- $a Šléglová, Olga $u Institute of Rheumatology, and Department of Rheumatology, 1st Faculty of Medicine, Charles University, Prague, Czech Republic
- 700 1_
- $a Gatterová, Jindřiška $u Institute of Rheumatology, and Department of Rheumatology, 1st Faculty of Medicine, Charles University, Prague, Czech Republic
- 700 1_
- $a Tomčík, Michal $u Institute of Rheumatology, and Department of Rheumatology, 1st Faculty of Medicine, Charles University, Prague, Czech Republic
- 700 1_
- $a Vencovský, Jiří $u Institute of Rheumatology, and Department of Rheumatology, 1st Faculty of Medicine, Charles University, Prague, Czech Republic
- 700 1_
- $a Pavelka, Karel $u Institute of Rheumatology, and Department of Rheumatology, 1st Faculty of Medicine, Charles University, Prague, Czech Republic
- 700 1_
- $a Šenolt, Ladislav $u Institute of Rheumatology, and Department of Rheumatology, 1st Faculty of Medicine, Charles University, Prague, Czech Republic. senolt@revma.cz
- 773 0_
- $w MED00001116 $t Clinical and experimental rheumatology $x 0392-856X $g Roč. 43, č. 3 (2025), s. 486-496
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/39808271 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20250415 $b ABA008
- 991 __
- $a 20250429134533 $b ABA008
- 999 __
- $a ok $b bmc $g 2311206 $s 1246770
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2025 $b 43 $c 3 $d 486-496 $e 20250110 $i 0392-856X $m Clinical and experimental rheumatology $n Clin Exp Rheumatol $x MED00001116
- LZP __
- $a Pubmed-20250415